Life ScienceCompany
Cymabay Therapeutics Ownership
Who owns Cymabay Therapeutics?
Cymabay Therapeutics is owned by Gilead Sciences. It was acquired on February 12, 2024.
Was Cymabay Therapeutics formerly PE-backed?
Yes. Cymabay Therapeutics was formerly owned by 3 private investors.
Cymabay Therapeutics Business Overview
Where is Cymabay Therapeutics headquartered?
Cymabay Therapeutics is headquartered in Newark, California.
What is Cymabay Therapeutics’ revenue?
Cymabay Therapeutics disclosed revenue of 10M USD for 2017 and 3M USD for 2012.
What sector is Cymabay Therapeutics in?
Cymabay Therapeutics is a life science company.
When was Cymabay Therapeutics founded?
Cymabay Therapeutics was founded in 1988.
Life Science M&A Summary in 2024
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.
Join Mergr to view all 186 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 172 by strategics.